DetailsChartProfilRisikomatrixNachrichtenDokumente

Candriam Equities L Oncology Impact R-H/  LU1864483083  /

Fonds
NAV16.05.2024 Diff.+0,1500 Ertragstyp Ausrichtung Fondsgesellschaft
194,1900EUR +0,08% thesaurierend Aktien weltweit Candriam ▶
 

Monatliche Performance

  Jan Feb Mrz Apr Mai Jun Jul Aug Sep Okt Nov Dez Gesamt
2021 - - - - - - - - - - - 3,80 -
2022 -10,61 -1,92 4,33 -6,01 -1,54 -0,31 4,18 -3,41 -5,17 6,64 5,71 -3,82 -12,68%
2023 1,90 -4,09 1,15 2,65 -2,80 -0,13 0,71 -2,23 -5,41 -6,53 8,95 5,51 -1,42%
2024 1,23 3,97 1,35 -3,54 4,89 - - - - - - - -

Kennzahlen

  lfd. Jahr 6 Monate 1 Jahr 3 Jahre 5 Jahre
Volatilität 10,88% 10,92% 11,78% -% -%
Sharpe Ratio 1,75 3,26 0,09 - -
Bester Monat +5,51% +8,95% +8,95% +8,95% -
Schlechtester Monat -3,54% -3,54% -6,53% -10,61% -
Maximaler Verlust -6,97% -6,97% -16,75% - -
Outperformance - - - - -
 
Alle Kurse in EUR

Tranchen

Titel   Ertragstyp Rückn. Preis 1 Jahr 3 Jahre
Candriam Equities L Oncology Imp... thesaurierend 2.400,9099 +7,62% +6,05%
Candriam Equities L Oncology Imp... thesaurierend 2.565,5000 +7,75% +6,45%
Candriam Equities L Oncology Imp... thesaurierend 207,9700 +4,02% -4,87%
Candriam Equities L Oncology Imp... thesaurierend 2.252,5000 +5,81% +17,09%
Candriam Equities L Oncology Imp... ausschüttend 1.611,3000 +7,27% +5,03%
Candriam Equities L Oncology Imp... thesaurierend 245,4500 +6,23% +14,09%
Candriam Equities L Oncology Imp... ausschüttend 236,2900 +6,27% +2,13%
Candriam Equities L Oncology Imp... ausschüttend 191,3300 +7,17% +4,73%
Candriam Equities L Oncology Imp... ausschüttend 20.796,0000 +3,23% +2,32%
Candriam Equities L Oncology Imp... thesaurierend 159,3600 +5,69% +16,70%
Candriam Equities L Oncology Imp... thesaurierend 2.114,3201 +5,00% -2,15%
Candriam Equities L Oncology Imp... thesaurierend 260,0600 +7,14% +17,01%
Candriam Equities L Oncology Imp... thesaurierend 207,4600 +3,60% -5,99%
Candriam Equities L Oncology Imp... thesaurierend 286,8900 +7,16% +4,72%
Candriam Equities L Oncology Imp... thesaurierend 194,1900 +4,88% -
Candriam Equities L Oncology Imp... thesaurierend 1.857,8800 +6,15% -
Candriam Equities L Oncology Imp... thesaurierend 2.884,1399 +7,27% +5,03%
Candriam Equities L Oncology Imp... thesaurierend 157,8100 - -
Candriam Equities L Oncology Imp... thesaurierend 274,5300 +6,26% +2,11%

Performance

lfd. Jahr  
+7,91%
6 Monate  
+17,90%
1 Jahr  
+4,88%
3 Jahre     -
5 Jahre     -
10 Jahre     -
seit Beginn
  -5,72%
Jahr
2023
  -1,42%
2022
  -12,68%